Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Percent of patients with hematocrit 33 or greater or hemoglobin 11 or greater

National Measure Source

Centers for Medicare and Medicaid Services (CMS), End Stage Renal Disease (ESRD) Clinical Performance Measures Project.

National Table

1.31a Percent of hemodialysis patients with hemoglobin 11 gm/dL or higher, United States, 2002 and 2003.

National Data Source

CMS, ESRD Clinical Performance Measures Project.

National Denominator

Medicare adult (age 18 and over) in-center hemodialysis (HD) patients or peritoneal dialysis (PD) patients, exclude patients with mean hemoglobin of 12g/dL or greater who are not prescribed Epotin at any time during the study period (HD patients: October to December, PD patient: January to March).

National Numerator

Subset of the denominator population with mean hemoglobin of 11g/dL or higher during the study period.

State Measure Source

University of Michigan Kidney Epidemiology and Cost Center, Unit Specific Report.

State Table

1.31b Percent of patients with hematocrit 33 or greater, by State, 2000 and 2003.

State Data Source

Data from the 2003 unit-specific report for dialysis patients, University of Michigan Kidney Epidemiology and Cost Center.

State Denominator

Medicare dialysis patients.

State Numerator

Subset of the denominator population with hematocrit 33 or greater.

Patient survival rate. Percent of hemodialysis patients with URR 65 percent or greater.

 

AHRQ Advancing Excellence in Health Care